Acura Pharmaceuticals Inc (ACUR)
0.01
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Acura Pharmaceuticals Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2017 | 0.309M |
September 30, 2017 | 0.306M |
June 30, 2017 | 3.808M |
March 31, 2017 | 7.979M |
December 31, 2016 | 10.80M |
September 30, 2016 | 11.82M |
June 30, 2016 | 6.055M |
March 31, 2016 | 2.357M |
December 31, 2015 | 0.108M |
September 30, 2015 | 0.973M |
June 30, 2015 | 3.576M |
March 31, 2015 | 0.851M |
December 31, 2014 | -0.002M |
September 30, 2014 | 1.296M |
June 30, 2014 | 3.058M |
March 31, 2014 | 6.258M |
December 31, 2013 | 6.253M |
September 30, 2013 | -16.93M |
June 30, 2013 | -19.05M |
March 31, 2013 | -20.04M |
December 31, 2012 | -20.13M |
September 30, 2012 | -0.206M |
June 30, 2012 | -0.188M |
March 31, 2012 | -0.163M |
December 31, 2011 | -0.131M |
Date | Value |
---|---|
September 30, 2011 | -0.063M |
June 30, 2011 | -0.078M |
March 31, 2011 | -0.066M |
December 31, 2010 | -0.041M |
September 30, 2010 | -0.039M |
June 30, 2010 | -0.147M |
March 31, 2010 | -0.207M |
December 31, 2009 | 4.819M |
September 30, 2009 | 4.818M |
June 30, 2009 | 4.899M |
March 31, 2009 | 3.838M |
December 31, 2008 | -5.181M |
September 30, 2008 | -5.172M |
June 30, 2008 | -5.13M |
March 31, 2008 | -4.009M |
December 31, 2007 | -0.009M |
September 30, 2007 | -0.073M |
June 30, 2007 | -0.078M |
March 31, 2007 | -0.019M |
December 31, 2006 | -0.015M |
September 30, 2006 | 0.053M |
June 30, 2006 | 0.062M |
March 31, 2006 | -0.009M |
December 31, 2005 | 0.158M |
September 30, 2005 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Oragenics Inc | -0.9363M |